/
CLAZF
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.10
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $475.2K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $18.9K | $0 | $0 | $0 | $0 |
| Gross profit | $475.2K | $0 | −$808 | −$18.9K | $0 | $0 | $0 | $0 |
| Gross margin | 100.0% | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $629.0K | $1.6M | $1.7M | $7.8M | $5.8M | −$2.1M |
| Operating income | −$13.6M | −$131.0K | −$1.4M | −$12.0M | −$14.5M | −$11.1M | −$9.5M | −$3.3M |
| EBITDA | −$6.3M | −$48.9K | −$1.4M | −$11.4M | −$15.4M | $18.1M | −$16.7M | $18.2M |
| Net income | −$20.0M | −$51.3K | −$1.4M | −$11.6M | −$31.9M | $6.9M | −$21.2M | $4.2M |
| Net margin | -4211.6% | — | — | — | — | — | — | — |
| EPS (diluted) | -183.89 | -0.47 | -1.92 | -7.80 | -5.20 | 0.64 | -1.00 | 0.16 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $0 | $-0.29 | $-0.29–$-0.29 | 1 |
| 2028 | $4M | $-0.15 | $-0.15–$-0.15 | 1 |
| 2029 | $4M | $0.00 | $0.00–$0.00 | 0 |
| 2030 | $4M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
CLARITAS PHARMACICLS INC
CLARITAS PHARMACICLS INC
Held by traders on TradeandTell
No one on the platform currently holds CLAZF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CLAZF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2009-04-21 | 1-for-2reverse |
Recent trades on TradeandTell
No one on the platform has traded CLAZF yet.